FdaApplication
NDA 210045
Identifiers
- fda_app_no: NDA210045
Properties
| Property | Value |
|---|---|
| applicant_name | PURPLE BIOTECH LTD |
| application_type | NDA |
| approval_date | 2018-05-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CONSENSI | AMLODIPINE BESYLATE; CELECOXIB | EQ 10MG BASE;200MG | TABLET;ORAL |
| CONSENSI | AMLODIPINE BESYLATE; CELECOXIB | EQ 2.5MG BASE;200MG | TABLET;ORAL |
| CONSENSI | AMLODIPINE BESYLATE; CELECOXIB | EQ 5MG BASE;200MG | TABLET;ORAL |
3 products